Concepedia

Jacqueline van Kuijk

JV

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2008

Affiliations

MSD (Netherlands)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Jacqueline van Kuijk is an author at MSD (Netherlands) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Publications per year

2008–2015

4

Publications

4

Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation

Pieter‐Jan de Kam, Jacqueline van Kuijk, Marita Prohn et al. · Clinical Drug Investigation · 2010 · 54 citations

, , +4

Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol

Luk Rombauts, Cornelis B. Lambalk, A. Schultze-Mosgau et al. · Fertility and Sterility · 2015 · 40 citations · Full text

, , +10

Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study

Pieter‐Jan de Kam, Jacqueline van Kuijk, Jean Smeets et al. · International Journal of Clinical Pharmacology and Therapeutics · 2012 · 33 citations

, , +17

Single IV sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium are not associated with QTc prolongation

Pieter‐Jan de Kam, Jacqueline van Kuijk, Marita Prohn et al. · European Journal of Anaesthesiology · 2008 · 10 citations

, , +7

1–4 of 4